UBS Group’s Pacer BioThreat Strategy ETF VIRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-974
| Closed | -$38.8K | – | 9347 |
|
|
2024
Q3 | $38.8K | Buy |
974
+890
| +1,060% | +$35.4K | ﹤0.01% | 5784 |
|
|
2024
Q2 | $3.05K | Hold |
84
| – | – | ﹤0.01% | 7102 |
|
|
2024
Q1 | $3.04K | Sell |
84
-726
| -90% | -$26.3K | ﹤0.01% | 6608 |
|
|
2023
Q4 | $26.2K | Buy |
810
+610
| +305% | +$19.7K | ﹤0.01% | 5727 |
|
|
2023
Q3 | $5.96K | Buy |
+200
| New | +$5.96K | ﹤0.01% | 6190 |
|
|
2023
Q2 | – | Sell |
-8
| Closed | -$234 | – | 8635 |
|
|
2023
Q1 | $234 | Sell |
8
-4,616
| -100% | -$135K | ﹤0.01% | 8027 |
|
|
2022
Q4 | $131K | Buy |
4,624
+33
| +0.7% | +$932 | ﹤0.01% | 4737 |
|
|
2022
Q3 | $116K | Buy |
4,591
+4,130
| +896% | +$104K | ﹤0.01% | 4543 |
|
|
2022
Q2 | $12K | Sell |
461
-2
| -0.4% | -$52 | ﹤0.01% | 6659 |
|
|
2022
Q1 | $14K | Buy |
463
+335
| +262% | +$10.1K | ﹤0.01% | 6926 |
|
|
2021
Q4 | $4K | Sell |
128
-221
| -63% | -$6.91K | ﹤0.01% | 8439 |
|
|
2021
Q3 | $11K | Buy |
349
+226
| +184% | +$7.12K | ﹤0.01% | 6770 |
|
|
2021
Q2 | $4K | Buy |
+123
| New | +$4K | ﹤0.01% | 7605 |
|